New things are coming to the Boston tech sector as companies are making more moves toward growth. Read up on the latest. This is the Built In Boston weekly refresh.
SalioGen Therapeutics got $20M. Having launched with its Series A funding, this biotech company is looking to develop its gene therapy platform. The company is inserting a new code to work toward treating a variety of diseases. The funding will go toward validating its platform in preclinical animal trials as it aims to enter the clinic by the end of 2023. [BostInno]
Everbridge grew its headcount in 2020. The event management firm is based in Burlington, and recently it updated its platform to enable managing COVID-19 vaccine appointments. Everbridge largely grew the size of its team, hiring 86 new members in Massachusetts alone last year. To date, the company employs 1,334 people full-time, up from 948 in 2019. [Boston Business Journal]
Boston Tech Quote of the Week
Lusha expands into Boston. With its first U.S. office, the Israeli data startup is looking to hire 20 new local roles in various positions. Its platform lets B2B salespeople share contact and company info with each other and provides them with data about their target customers. The company also brought on Boston-based Henry Spitzer as its VP of sales. [Built In Boston]
Gig workers are defending their rights. In Massachusetts, legislators are considering a bill that would give Uber and Lyft drivers considerably fewer benefits as contractors than if they were to be considered employees. The legislation is similar to California’s AB5. In response, the Boston Independent Drivers Guild published its own bill of rights as its members continue to fight for employee status. [Vice]
